Balaxi Pharmaceuticals Limited

Share · INE618N01014 (XNSE)

Overview

No Price

Closing Price XNSE 28.10.2025: 41,65 INR

28.10.2025 09:58

Current Prices from Balaxi Pharmaceuticals Limited

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NSE	BALAXI.NS	INR	28.10.2025 09:58	41,65 INR	-0,42 INR -1,00 %

Share Float & Liquidity

Free Float 29,63 %

Shares Float 3,3 M

Shares Outstanding 11,13 M

Company Profile for Balaxi Pharmaceuticals Limited Share

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana. The Company’s products include pharmaceuticals products, food products and builders’ hardware products. The company operates through the operating segment international wholesale trading. Its pharmaceutical formulations and builders’ hardware products are contract manufactured from manufacturing plants in India. The firm offers a range of food and biscuit products under the brand name YAP. Its subsidiaries include Balaxi Global DMCC.

Get up to date insights from finAgent about Balaxi Pharmaceuticals Limited

Company Data

Name Balaxi Pharmaceuticals Limited

Company Balaxi Pharmaceuticals Limited

Website http://www.balaxiventures.in

Primary Exchange

NSE

ISIN INE618N01014

Asset Class Share

Sector Healthcare

Industry Medical - Equipment & Services

CEO Ashish Maheshwari

Market Capitalization 477 Mio

Country India

Currency INR

Employees 0,1 T

Address MAPS Towers, 500096 Hyderabad

IPO Date 2015-12-02

Ticker Symbols

Name	Symbol
NSE	BALAXI.NS

More Shares

Investors who hold Balaxi Pharmaceuticals Limited also have the following shares in their portfolio:

AIM ETF Products Trust AllianzIM U.S. Large Cap Buffer10 Jun ETF ETF

PLEXUS HOLDINGS PLC - ORD 1P Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog